Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment.
Saved in:
| Title: | Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. |
|---|---|
| Authors: | Kerr DL; Department of Medicine, University of California, San Francisco, CA, USA., Haderk F; Department of Medicine, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA. Electronic address: franziska.haderk@ucsf.edu., Bivona TG; Department of Medicine, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA. Electronic address: trever.bivona@ucsf.edu. |
| Source: | Current opinion in chemical biology [Curr Opin Chem Biol] 2021 Jun; Vol. 62, pp. 1-12. Date of Electronic Publication: 2021 Jan 06. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9811312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0402 (Electronic) Linking ISSN: 13675931 NLM ISO Abbreviation: Curr Opin Chem Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-0402 |
|---|---|
| DOI: | 10.1016/j.cbpa.2020.11.007 |
